Pediatrics
News
Hormonal contraceptives tied to leukemia in progeny
A nationwide cohort study suggests an association between a woman’s use of hormonal contraceptives and leukemia in her offspring. Children of...
News
Neurotoxicity risk is higher for Hispanic kids with ALL
In a prospective study, Hispanic pediatric patients with acute lymphoblastic leukemia (ALL) had a risk of methotrexate-induced neurotoxicity that...
From the Journals
Levofloxacin prophylaxis cuts bacteremia in pediatric acute leukemias
Bacteremia risk was not significantly reduced in another cohort of children undergoing hematopoietic stem cell transplantation, however.
From the Journals
Hormonal contraceptive use linked to leukemia risk in offspring
Maternal use of hormonal contraceptives close to pregnancy is associated with a small increase in the risk of nonlymphoid leukemia in offspring....
From the Journals
Hispanic ALL patients face higher treatment toxicity
A prospective study found higher rates of methotrexate toxicity among Hispanic children than among non-Hispanic white children.
News
First CAR T-cell therapy approved in Canada
Health Canada has authorized use of tisagenlecleucel (Kymriah™), making it the first chimeric antigen receptor (CAR) T-cell therapy to receive...
News
Escalating MTX appears superior for T-ALL
Escalating methotrexate (MTX) may produce better outcomes than high-dose MTX in children and young adults with T-cell acute lymphoblastic leukemia...
News
CAR T-cell therapy will soon be available in England, NHS says
The National Health Service (NHS) of England has announced that tisagenlecleucel (Kymriah®), a chimeric antigen receptor (CAR) T-cell therapy,...
News
EC approves blinatumomab for kids
The European Commission (EC) has expanded the approved indication for blinatumomab (Blincyto®), a bispecific, CD19-directed, CD3 T-cell engager...
Latest News
European Commission approves first CAR T-cell therapies
Tisagenlecleucel and axicabtagene ciloleucel can now be marketed throughout Europe.
Conference Coverage
Integrated pain program reduced LOS for sickle cell patients
WASHINGTON – The small study is another data point showing the importance of multidisciplinary care.